6ix — Find Your Next Investment

Discover investor relations events, company profiles, and investment opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

About

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) — investor relations, events, news, and company updates on 6ix.

Latest News

Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right

Aurinia Announces Management Transition

Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provides Update on Recent Business Progress

Aurinia Pharmaceuticals to Report Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provide Update on Recent Business Progress on February 26, 2026

Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2025 and Provides Update on Recent Business Progress

Financials

Revenue

$283.06 M

Market Cap

$2.08 B

P/E Ratio

7.54

EPS

2.07

Community Chat

Ask AI

Original text

Rate this translation

Your feedback will be used to help improve Google Translate